Related Experiment Videos
Sentinel lymph node biopsy in head and neck cancer
Karen T Pitman1, Alfio Ferlito, Kenneth O Devaney
1Department of Otolaryngology, University of Mississippi Medical Center, Jackson, MS, USA.
Oral Oncology
|April 5, 2003
Summary
Sentinel lymph node biopsy (SLNB) shows promise for head and neck cancers, potentially reducing treatment complications. However, its efficacy compared to melanoma and breast cancer requires further investigation before widespread adoption.
Area of Science:
- Oncology
- Surgical Pathology
Background:
- Sentinel lymph node biopsy (SLNB) is increasingly used for various cancers, including melanoma and breast cancer.
- Cervical node dissection for head and neck cancers carries known complications.
- SLNB is hypothesized to reduce morbidity in head and neck cancer treatment.
Purpose of the Study:
- To assess the current status and potential utility of SLNB in head and neck cancer management.
- To evaluate if SLNB can offer similar benefits as seen in melanoma and breast cancer patients.
Main Methods:
- Review of current literature and clinical experience with SLNB in head and neck cancers.
- Comparison of SLNB utility in head and neck cancers versus established applications in melanoma and breast cancer.
Main Results:
- SLNB has been applied to a wide range of primary neoplasms.
- Experience is greatest in melanoma and breast cancer patients.
- SLNB in head and neck cancers is still considered experimental and not standard care.
Conclusions:
- SLNB shows potential for reducing morbidity in head and neck cancer treatment.
- Formal investigations into SLNB efficacy in head and neck cancers are recommended.
- SLNB is not yet a standard of care for head and neck cancers, unlike in melanoma and breast cancer.